Background It has been suggested that cervical ripening with a balloon catheter for labour induction can be done in an outpatient setting in low-risk pregnancies. Introduction of such an approach needs to be accompanied with monitoring of potential complications. Therefore the existence and frequency of any associated adverse event during cervical ripening needs to be established.
Introduction
Induction of labour is one of the most commonly performed obstetric interventions in well-resourced countries.
Approximately 25% of all term pregnancies are induced. 1 Labour induction results in better clinical outcomes for both women and their babies if the associated maternal/ fetal risks are lower than the risks of continuation of the pregnancy. 2 Cervical ripening is part of induction of labour which aims to relax and soften the cervix prior to onset of *Both authors contributed equally to this review. uterine contractions. Worldwide the transcervical balloon catheter is used as a mechanical method for cervical ripening. It stretches the cervix and stimulates the release of local decidual and cervical prostaglandins. Two previous reviews show that the balloon catheter is an effective method for cervical ripening as compared with pharmacologic induction with prostaglandins. 3, 4 The concept of outpatient induction of labour is an attractive alternative to inpatient care both economically and on the grounds of patient satisfaction. 5, 6 The balloon catheter has lower rates of excessive uterine activity in comparison with prostaglandins, which could make it a more suitable and attractive induction method for use in an outpatient setting. [7] [8] [9] Outpatient management for cervical ripening in low-risk pregnant women has therefore been proposed. 10 Knowledge on the safety of such a policy is crucial, especially the occurrence of adverse events between the moment of insertion and expulsion of the balloon catheter, as women in this period are not under strict hospital monitoring. The aim of this systematic review is to assess the patient safety of labour induction with a transcervical balloon catheter between introduction and expulsion of the balloon, and to thereby determine the risk of adverse events during the period women would go home in an outpatient setting.
Methods

Data sources
We searched Embase, Medline, Cochrane Collaboration and the Cumulative Index to Nursing and Allied Health Literature (CINAHL) up to 10 October 2016 for randomised controlled trials (RCTs) and cohort studies on cervical ripening or labour induction with a balloon catheter. Search terms used were 'induction of labour', 'cervical ripening', 'balloon catheter', 'Foley balloon' and 'transcervical balloon'. These terms were developed in collaboration with a medical librarian. No restrictions in relation to language or date were applied. Details of the search strategy are documented in Appendix S1.
Inclusion criteria
We only considered RCTs and cohort studies with more than 400 participants that contained original data on the occurrence of adverse events during labour induction by a transcervical balloon catheter in pregnant women with unfavourable cervices and live fetuses in vertex position. We considered studies carried out in the inpatient hospital setting and in the outpatient setting. Both high-and low-risk pregnant women, referred to secondary care, receiving interventions with a balloon catheter regardless of sort (single versus double) or volume were included. Articles that explicitly reported on the absence of adverse events in all participants were also included. Studies were excluded if labour was induced for pregnancy termination or intrauterine fetal death. Articles that combined use of the balloon catheter with concurrent administration of other pharmacological and mechanical methods or used the balloon catheter as a second option after first induction failed were also excluded. Studies that administered oxytocin or performed artificial rupture of membranes (ARM) for augmentation of labour after spontaneous expulsion or removal of the balloon catheter were not excluded. To be selected, the study had to record at least one of the adverse events mentioned in Table 2 during the in situ period of the balloon catheter. If studies met the inclusion and exclusion criteria, the original authors were contacted for specific information on the occurrence/recording of adverse events between balloon insertion and expulsion. An article was excluded if adverse events were not recorded for all study participants or if they did not occur in this exact time frame. If authors were not traceable, the article was also excluded.
Study selection
Two reviewers (M.D. and J.G.) independently reviewed the titles and abstracts of all potential studies, followed by fulltext selection. Disagreement was resolved by discussion and consensus; if needed, the opinion of a third author (B.W.M.) was decisive.
Data abstraction and quality assessment M.D. and J.G. emailed individual authors to request specific information on the time frame and course of the adverse events reported in tables, graphs, and text, as well as the indication for induction. If data on recording/occurrence of complications (see Table 2 ) during the in situ period of the balloon catheter were already provided in the manuscript, this information was directly extracted from the article. There were no discrepancies between the author's response and the published data. The included data were extracted by the intention-to treat principle using a data extraction file based on the Cochrane process. 11 The quality of eligible studies was evaluated independently by the two reviewers according to the standardised critical appraisal instruments from the Joanna Briggs Institute Meta-Analysis of Statistics Assessment and Review Instrument (JBI-MAStARI). 12 
Data analysis
Data on maternal and fetal morbidity during cervical ripening were pooled and individual cases of complications were discussed. The proportion of complication rate was pooled using the rme function (DerSimonian Laird estimator) within 'metafor' package in R (version 3.3.1) and reported with 95% confidence intervals (CI). We analysed our data with double arcsine transformation (Freeman-Tukey) because of the expectation that most studies will report a low prevalence. To measure the amount of between-study variation that is due to systematic heterogeneity rather than chance, the heterogeneity was evaluated by calculating the I 2 metric. We used the PRISMA guidelines and checklist (2009) for conducting this systematic review. 13 
Results
Study selection and characteristics
After duplicate selection, a total of 585 studies were screened for eligibility by title and abstract, of which 97 studies were eligible for full-text assessment ( Figure S1 ). In total, 36 articles were excluded because: contact details of authors were not traceable (n = 18), other pharmacologic methods were used concurrently (n = 4), there was induction for intrauterine fetal death (n = 5), cohort size <400 (n = 2), no original data were used (n = 3) or other reasons (n = 4). Appendix S2 provides a list of excluded articles. Overall, the methodologic quality of the studies was good and therefore no studies were excluded after methodologic quality assessment. We emailed 61 authors with a request for specific information on the occurrence of adverse events between balloon catheter insertion and expulsion. We got 27 responses, two of which indicated that they were not able to supply information. The other 34 authors did not respond, even after sending reminders and resending the mail to co-authors. One RCT was included after study selection to update the results of the review. In total, 26 studies (8292 women) were identified as eligible for inclusion, of which 21 were RCTs, two prospective, and three retrospective cohort studies. Two studies were carried out (partially) in an outpatient setting and 23 were conducted in an inpatient hospital setting. A total of 22 studies reported on a single balloon catheter, one study on a double balloon catheter, two studies compared both catheter types, and this information was unknown for one study. Balloon volumes ranged from 30 to 80 ml. Other study characteristics are shown in Table 1 .
Adverse events during cervical ripening with a balloon catheter Table 2 shows the adverse events that occurred during cervical ripening between insertion and expulsion of the balloon catheter. Per adverse event, we only included data of studies that recorded this adverse event for all study participants. Therefore the total number of participants per adverse event differs (Table 2) . Table S1 shows which articles were included in the analyses per adverse event. The following adverse events were reported: pain/discomfort; unintended amniotomy; vaginal bleeding; balloon displacement; non-reassuring fetal heart rate; allergic reaction; voiding problems; balloon rupture; uterine hyperstimulation; uterine hypertonus; decreased fetal movements and malpresentation. Figure 1 shows the proportion of complication rates using random effect models for adverse events for which the occurrence rates are high enough to be pooled reliably. As the occurrence rate was too low for the other adverse events, we were not able to pool the data reliably. The heterogeneity across the studies was substantial (I 2 varied between 48.63 and 85.42%).
Indication for induction
The reason for induction, listed per study and per adverse event, is displayed in Table S2a and S2b. The overall reason for induction was most often post-term pregnancy. The reason for induction in women who had an adverse event during cervical ripening was also most often post-term pregnancy (Table S2a and S2b).
In the following, both adverse events that were reliably pooled as well as the events that were not pooled are discussed. A more detailed discussion of the data of the adverse events that have been pooled can be found in Appendix S3.
Pain/discomfort
There were 17 studies (5754 women) that reported on pain/discomfort. A total of six studies reported on the occurrence in 31 women. The estimated prevalence of pain/discomfort across the studies in the random effects model was 0.26% (95% CI 0.00-1.01%). In some women the catheter had to be removed, [14] [15] [16] but mostly induction of labour was continued normally.
10,17
Unintended amniotomy
There were 12 studies (2989 women) that reported on unintended amniotomy. Two studies reported on the occurrence in 19 women. The estimated prevalence of unintended amniotomy across the studies in the random effects model was 0.04% (95% CI 0.00-0.69%). In these women either a different method of induction was performed 18 or induction was continued with the balloon catheter and prophylactic antibiotics were started. 19 No infections due to the unintended amniotomy occurred.
Vaginal bleeding
There were 18 studies (6566 women) that reported on vaginal bleeding. A total of 10 studies reported on the occurrence in 18 women. The estimated prevalence of vaginal bleeding across the studies in the random effects model was 0.07% (95% CI 0.00-0.33%). In some women, the catheter had to be removed and ripening had to be pursued with a different method. 20 In other women, the bleeding resolved spontaneously and induction with the catheter was continued. 10, 21 In three cases a caesarean section (CS) was performed due to severe bleeding and in one woman due to a marginal placenta praevia. 18, 19, 22 Two of these neonates had good Apgar scores and information of the third one was not available to us.
Balloon displacement
There were 10 studies (2397 women) that reported on balloon displacement. Four studies reported on the occurrence in 12 women. The estimated prevalence of balloon displacement across the studies in the random effect model was 0.07% (95% CI 0.00-0.62%). In most women, a different method of induction was used after displacement of the balloon catheter. 8, 9, 20 Non-reassuring fetal heart rate There were 17 studies (5351 women) that reported on non-reassuring fetal heart rate after balloon insertion.
Five studies reported 15 cases of non-reassuring fetal heart rate with an estimated prevalence across the studies in the random effects model of 0.01% (95% CI 0.00-0.22). In some women, the induction of labour was continued normally 9 or the balloon catheter was removed. 18, 19 In other women a CS was performed. 19, 23, 24 Only in two cases was a neonate born with low Apgar scores and these neonates were admitted to the NICU for no longer than 5 days.
9,19
Allergic reaction
There were 16 studies (6832 women) that reported on allergic reaction, of which two studies reported a total of two allergic reactions. 15, 20 One woman with a known latex allergy experienced mild symptoms but there was no Prospective cohort n/a n/a n/a 100 Jozwiak et al. 15 
411
RCT suspicion of anaphylactic shock. After removal, misoprostol was given and a CS was performed. A neonate was delivered (Apgar scores 6/9) without NICU admission. 20 Information about the other woman was not available to us.
Voiding problems
There were 10 studies (3522 women) that reported on voiding problems. Only one study reported that two women had to return to the hospital because of difficulties urinating at home. 10 They presented with the Foley catheter expulsed in the vagina, and after catheter removal they could urinate normally again. Both women had a Bishop score of 6 and induction of labour was continued with amniotomy and oxytocin.
Balloon rupture
There were 12 studies (3222 women) that reported on balloon rupture. Only one study reported one woman with balloon rupture in the outpatient setting. 10 She returned to the hospital 4 hours after insertion because of balloon rupture and subsequent catheter expulsion. As the Bishop score was 7, induction of labour was continued with amniotomy and oxytocin. A healthy neonate was delivered vaginally.
Abnormal uterine activity
There were 20 studies (4812 women) that reported on uterine hyperstimulation. Only one study reported one woman with hyperstimulation (more than five uterine contractions in 10 minutes in a consecutive 30-minute interval), who did not respond to tocolytic agent and had a CS.
There were 14 studies (3707 women) that reported on uterine hypertonus. One study reported one woman with hypertonus after Foley catheter insertion, without CTG abnormalities. 7 The intervention was discontinued and artificial rupture of the membranes was done the next morning. Information about the outcome of the neonate was not available.
Decreased fetal movements
There were 11 studies (4318 women) that reported on decreased fetal movements, of which one study reported on the occurrence of one event. 10 This woman had a normal CTG and induction of labour was continued uneventfully : only data for outpatient group on this adverse events. **de Oliveira e Oliveira et al. 17 : one women with vaginal bleeding, this woman was excluded from their analysis but included in this review. The sample size of the intention-to-treat was maintained. ***Salim et al. 16 : only data for DBC group on this adverse event; one women with discomfort in the DBC group, this woman was excluded from their analysis but included in this review. The sample size of the intention-to-treat was maintained. in an inpatient setting with the delivery of a healthy neonate.
Malpresentation
There were 16 studies (6046 women) that reported on malpresentation. A total of three studies reported on the occurrence in four women. In one case, altered presentation from vertex to breech was noticed just after the double balloon catheter fell out the morning after insertion. 25 A healthy neonate was delivered by a CS. One study reported one case of face presentation during their study period with a single balloon catheter, after which a CS was performed. Another study described two cases of non-cephalic presentation which was noticed just after Foley catheter removal. Prior to insertion of the Foley catheter, an ultrasound confirmed a cephalic presentation. Therefore it was assumed that the rotation occurred during cervical ripening. Both women delivered healthy neonates via a CS.
Discussion
Main findings
In this study, we reviewed the occurrence of adverse events during the in situ period of the balloon catheter to assess the safety for outpatient management of cervical ripening. Among the 8292 women included, the estimated prevalence of the analysed adverse events in the random effects model was between 0.0 and 0.26%. Some adverse events resulted in a CS, but mostly the induction of labour with the balloon catheter was continued without any concerns. Almost all the included studies used a single balloon catheter, thus precluding a statement on the occurrence of adverse events in the single versus double balloon group. This was also the case in relation to applying tension or no tension on the balloon catheter.
Strengths and limitations
As far as we know, this is the first systematic review that analyses occurrence of adverse events during the in situ period of the balloon catheter used for cervical ripening as part of labour induction. We included only RCTs and large cohort studies to prevent publication bias. We obtained information by emailing authors for specific information on their studies, which enabled us to collect data from a large study population. Therefore our pooled data reflects the real complication risk in the most robust way possible. As we analysed a large number of both major and minor adverse events, we were able to assess the occurrence rate of a wide spectrum of complications during cervical ripening which makes our insight into the possible risks as comprehensive as possible. These adverse events were selected because of their clinical importance in the context of outpatient care and/or because they were commonly reported in the literature.
This study also has its limitations. We only obtained data from authors who replied to our request, which made us dependent on the accuracy of the information provided by them. Besides this, included studies were heterogeneous in design, method of intervention, and demographic characteristics. Some women had a previous CS and the volumes of balloon catheters that were used varied between 30 and 80 ml. Unfortunately, there was no standardised set of outcome measures related to safety while assessing the included studies. Another limitation is that we did not record adverse events that occurred during the period between balloon catheter expulsion and re-admission. This may have led to us missing data and could result in a higher occurrence rate of adverse events during outpatient management. Additionally, exclusion of cohort studies smaller than 400 participants might lead to an overestimate of the prevalence.
Interpretation
The focus of this review is outpatient care, which has been proposed for low-risk pregnancies. Notwithstanding, we also included data on high-risk women in the inpatient setting who have much higher risks of developing complications. Therefore the real risk of developing an adverse event during cervical balloon ripening in low-risk pregnancies will likely be lower than our results imply. Besides this, high-risk women with at least one previous CS were included, which has been associated in previous studies with a higher occurrence of uterine rupture or scar dehiscence. [26] [27] [28] Even though outpatient cervical ripening would generally be unsuitable for these high-risk women, the occurrence rate of 'uterine rupture/scar dehiscence' was still zero. In the case of excessive uterine activity, induction of labour with a balloon catheter is mostly recommended because of low occurrence rates. [7] [8] [9] The data in this systematic review showed similar results with only one case of uterine hyperstimulation and one case of hypertonus during the in situ period. Furthermore, we found one case of malpresentation, which was detected immediately after balloon catheter expulsion. This does not seem to have direct implications for induction in the outpatient setting, because this adverse event would probably also have been detected in the hospital setting after catheter expulsion, as there is not a regular check of the fetal position with ultrasound during the night in the hospital. These findings in our review would therefore not have any direct consequences for outpatient care. Some of the adverse events such as non-reassuring fetal heart rate and vaginal bleeding occurred directly after balloon catheter insertion. These adverse events would therefore be diagnosed in the clinical setting and the women would not be suitable for outpatient care. In the case of minor events, women will most likely have enough time to come to the hospital to resolve the problem and to continue the intervention. Although the occurrence of minor events is important to bear in mind, it does not directly restrain possible future implementation of outpatient care. Another important adverse event is prolapse of the umbilical cord, as this can induce fetal hypoxia. The study of Hasegawa et al. 29 concludes that the risk of umbilical cord prolapse was significantly increased during the use of transcervical balloons for cervical ripening. In contrast to this, the included studies in this systematic review did not report on the occurrence of cord prolapse during cervical ripening. As mentioned before, induction of labour in the outpatient setting is only suitable for low-risk pregnancies. A possible risk might be that a pregnancy appears to be uncomplicated but eventually unrecognised complications present. These women would be categorised as lowrisk and therefore seem suitable for home induction, whereas the pregnancy is actually high-risk. Two recent studies have shown that in apparently uncomplicated pregnancies, small-for-gestational age occurred in 7.9 and 10.8%. 30, 31 These neonates had higher rates of composite neonatal morbidity and therefore inpatient induction of labour in women with SGA infants is indicated as more appropriate. Clinicians should be aware of this possible risk. That being said, they should bear in mind that all home-induced women return to the hospital for delivery. In the case that a seemingly low-risk pregnant woman presents with unrecognised complications, the actual labour and delivery will be in the hospital where neonatal care is available.
Conclusion
Our findings suggest a low-risk of developing an adverse event in the period between insertion and expulsion. The findings support the consideration of the implementation of outpatient cervical ripening with a balloon catheter in low-risk pregnant women after a thorough clinical assessment post-insertion. As severe complications cannot be excluded completely by our study, further research, preferably in the form of observational cohort studies, should be performed to support our statement on outpatient balloon catheter use in low-risk pregnancies.
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